South Korea Moves to Expedite, Simplify Approvals of Vaccines, Orphan Drugs
To speed the import of key new biologic agents needed to combat public health emergencies, including vaccines to help the body develop immunity to the virus that causes COVID-19, South Korea is cutting the steps required for regulatory approval of the products. The... Read More